-Adrenergic
Receptors by Ca2+ Sensitization in Tracheal Smooth Muscle
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Lysophosphatidylcholine (Lyso-PC) is generally considered to
promote tissue inflammation. To determine the involvement
of exogenous Lyso-PC in the
-adrenergic desensitization by
phospholipase A2, we examined the inhibitory effects of isoproterenol (ISO) on tension and intracellular Ca2+ concentration by methacholine (MCh) after continuous exposure to
Lyso-PC in guinea-pig tracheal smooth muscle, using isometric tension recordings and fura-2 signal (F340/F380 ratio). Pre-
exposure to 10 µM Lyso-PC markedly reduced subsequent inhibition by 0.3 µM ISO against 1 µM MCh-induced contraction
in a time-dependent manner. In contrast, values of percent
F340/F380 ratio for MCh with ISO were not affected after exposure to Lyso-PC. In the presence of Y-27632, a selective rho-kinase inhibitor, a reduction in subsequent relaxation by ISO
after exposure to Lyso-PC was inhibited in a concentration-dependent manner. Preincubation with cholera toxin also inhibited reduced responsiveness to ISO by Lyso-PC. Pre-exposure to Lyso-PC did not attenuate subsequent relaxation by agents
that bypass
-adrenergic receptors. These results indicate that
continuous exposure to Lyso-PC may cause homologous desensitization of
-adrenergic receptors via an augmentation in
sensitivity to Ca2+ by rho, a small G protein, in airway smooth
muscle, and that activation of the stimulatory G protein of
adenylyl cyclase, Gs, may prevent this phenomenon.
| |
Introduction |
|---|
|
|
|---|
Phospholipase (PL) A2 is a membrane-bound lipolytic enzyme that regulates the conversion of glycerolphospholipids to lysophospholipids, a precursor of platelet-activating factor (PAF), and free fatty acids such as arachidonic acid (AA), the substrate for synthesis of biologically active eicosanoids. Therefore, activation of PLA2 is generally considered to be implicated in the pathophysiology of bronchial asthma. On the other hand, lysophosphatidylcholine (Lyso-PC) is another type of lysophospholipid which is synthesized from phosphatidylcholine by PLA2 in the cell membrane; however, the role(s) of Lyso-PC in the pathogenesis of this disease remains unclear. Although Lyso-PC is not a precursor of PAF and eicosanoids, this lysophospholipid has been demonstrated to correlate with hyperreactivity to histamine in guinea pigs (1) and humans (2). Previous clinical trials also have demonstrated that antigen inhalation causes a marked augmentation in values of not only PLA2 and AA but also Lyso-PC in bronchoalveolar lavage in patients with atopic asthma (3, 4). Moreover, inasmuch as it has been revealed that extracellular application of Lyso-PC induces expression of adhesion molecules such as intracellular adhesion molecule-1 and vascular cell adhesion molecule-1 on the surface of endothelial cells (5), this lysophospholipid may be involved in the infiltration of leukocytes, including eosinophils, in airways. These results indicate that the extracellular generation of Lyso-PC by secretory PLA2 may promote tissue inflammation, and, moreover, that chronic exposure to Lyso-PC may be responsible for some of the pathophysiology of bronchial asthma.
Reduced responsiveness to
-adrenergic receptor agonists (
-agonists) is well known to be a characteristic feature of bronchial asthma. This undesirable dysfunction of
-adrenergic receptors may be mediated by proinflammatory cytokines that participate in the airway inflammation
of this disease (6, 7). Previous reports have demonstrated
that preincubation with PLA2 leads to a reduction in sensitivity to
-agonists in lung membrane (8), and that preincubation with AA also causes a reduction in subsequent relaxation by
-agonists in airway smooth muscle (9, 10). Because the reduced responsiveness to
-agonists by AA
is prevented in the presence of indomethacin, a cyclooxygenase inhibitor, synthesis of eicosanoids is directly involved in causing desensitization of the
-adrenergic receptors. PLA2/AA processes are generally considered to
play an important role in not only airway inflammation but also desensitization to
-agonists, similar to these cytokines. However, little is currently known about the involvement of exogenous Lyso-PC in the pathophysiology
of bronchial asthma.
This study was designed to determine causal relationships
between chronic exposure to lysophospholipids and
-adrenergic desensitization in airway smooth muscle. We examined subsequent response to
-agonists after continuous
exposure to Lyso-PC in isolated guinea-pig tracheal smooth
muscle. Moreover, we examined the involvement of signal transduction processes as the mechanisms underlying the
reduced responsiveness to
-agonists by Lyso-PC.
| |
Materials and Methods |
|---|
|
|
|---|
Tissue Preparation and Tension Records
The methods were essentially similar to those described previously (11, 12). Male guinea pigs (350 to 450 g) were killed by stunning and bleeding, and tracheas were excised from the animals. The tracheal ring was opened by cutting longitudinally through the cartilaginous region and the epithelium was dissected away. The muscle strips containing one cartilaginous ring were removed. Muscle strips were placed vertically in a 1-ml organ bath
to measure tension isometrically, and were perfused with solution at a constant flow rate 2 ml/min throughout the experiments.
The normal bathing solution had the following composition (in
mM): 137 NaCl, 5.9 KHCO3, 2.4 CaCl2, 1.2 MgCl2, and 11.8 glucose, bubbled with a gas mixture of 99% O2/1% CO2. For the
Ca2+-free solution, 2.4 mM CaCl2 was replaced with 2.2 mM
NaCl and 0.2 mM ethyleneglycol-bis-(
-aminoethyl ether)-N,N',-tetraacetic acid. The passive tension was adjusted to 0.5 g after
equilibrating the preparation in the normal bathing solution for
60 min. The quantity of 1 µM methacholine (MCh) was applied to
the strips for 10 min at intervals of 20 min until the control response to 1 µM MCh was established, then the experiments were
started. Indomethacin (2 µM) was perfused throughout the experiments to abolish the resting tone. The relaxation induced by
exposure to the Ca2+-free solution was defined as complete relaxation (0% contraction). The Ca2+-free solution was applied to
the tissues at the end of each experiment to determine the level
of 0% contraction. All experiments were carried out at 37°C.
Measurement of Fura-2 Fluorescence
Segments containing two cartilaginous rings were placed horizontally in a chamber (0.6 ml volume). One end of the segment was fixed to the chamber and the other end was connected to a force-displacement transducer. The muscle strips of guinea-pig tracheas were treated with 10 µM acetoxymethyl ester of fura-2 (fura-2/AM) for 4 h at room temperature (22 to 24°C). The noncytotoxic detergent, pluronic F-127 (0.01% wt/vol), was added to increase the solubility of fura-2/AM. After loading, the chamber was perfused with the normal bathing solution at 37°C for 50 min to wash out the extracellular fura-2/AM before the measurements were taken. According to the method described previously (13), isometric tension and the fura-2 fluorescence of muscle strips were measured simultaneously, using a displacement transducer and a spectrofluorometer (CAF-110; Japan Spectroscopic, Tokyo, Japan). The mucosal side of the muscle strips was exposed to the excitation light, and the light emitted from the strip was collected into a photomultiplier through a 500-nm filter. The intensity of fluorescence due to excitation at 340 nm (F340) and that at 380 nm (F380) were measured after background subtraction. The absolute amount of intracellular Ca2+ concentration ([Ca2+]i) was not calculated because the dissociation constant of fura-2 for Ca2+ in smooth muscle cytoplasm may be different from that obtained in vitro (14). Therefore, the ratio of F340 to F380 (F340/ F380 ratio) was used as a relative indicator of [Ca2+]i. To assess the contamination of Ca2+-independent fluorescence mediated by intermediate metabolites of fura-2/AM, photobleached fura-2, and changes in the cell geometry, we checked that F340 and F380 move in opposite directions when [Ca2+]i is changed. Muscle tension and F340/F380 ratio in the resting state were defined as 0%. Percent contraction and percent F340/F380 ratio were expressed by taking response to 1 µM MCh as 100%.
Experimental Protocols
To determine the effects of Lyso-PC on
-adrenergic receptors in
airway smooth muscle, response to MCh in the presence of isoproterenol (ISO) was examined before and after continuous exposure of the tissues to Lyso-PC. MCh (1 µM) was applied to the
tissues for 10 min and the normal bathing solution was perfused
for 15 min to wash out this agent. The quantity of 1 µM MCh was
again applied in the presence of 0.3 µM ISO for an equivalent
time, and the normal bathing solution was perfused for 15 min to
wash out these agents. Then 10 µM Lyso-PC was perfused for 15, 60, and 120 min. After continuous exposure to Lyso-PC, the normal bathing solution was perfused for 15 min to wash out Lyso-PC. Next, MCh and MCh with ISO were applied to the identical
tissues in the same way. To obtain concentration-inhibition
curves for ISO on MCh, ISO was cumulatively applied to the tissues precontracted by 1 µM MCh at intervals of 10 min at each
concentration before and after exposure to the normal bathing
solution and 10 µM Lyso-PC for 120 min. The curves for ISO on
MCh were constructed after exposure to the normal bathing solution and Lyso-PC. To determine the role of intracellular cyclic
adenosine monophosphate (cAMP) in the effects of exposure to
Lyso-PC, we examined the effects of exposure to Lyso-PC on the
relaxant effects of agents that increase concentration of cAMP,
bypassing
-adrenergic receptors such as forskolin (a direct activator of adenylyl cyclase), theophylline (a nonselective phosphodiesterase inhibitor), and db-cAMP (the stable analog of cAMP).
Concentration-inhibition curves for these agents on MCh were
constructed in the same way. To determine the effects of Lyso-PC on MCh-induced contraction, MCh was cumulatively applied
for 10 min at each concentration before and after exposure to
Lyso-PC. Concentration-response curves for MCh were constructed in the same way. To determine the involvement of rho, a
small monomeric G protein, in the effects of exposure to Lyso-PC,
Y-27632, a selective inhibitor of rho-kinase, was perfused throughout the experiments to exclude the effects of Y-27632 on muscarinic and
-adrenergic action. To determine the involvement of
protein kinase (PK) C in this phenomenon, 5 µM bisindolylmaleimide (BIS), a membrane-permeable inhibitor of PKC, was applied 30 min before exposure to 10 µM Lyso-PC and then the tissues were incubated with Lyso-PC and BIS for 120 min. To
determine the involvement of a pertussis toxin (PTX)-sensitive
G protein (Gi) in this phenomenon, the tissues were incubated
with 1 µg/ml PTX for 6 h; then after the normal bathing solution
was perfused for 15 min to wash them out, the tissues were exposed to 10 µM Lyso-PC for 120 min. To determine the involvement of the stimulatory G protein of adenylyl cyclase, Gs, the tissues were incubated with 2 µg/ml cholera toxin (CTX), and after
washout, Lyso-PC was perfused in the same way. Moreover, concentration-inhibition curves for prostaglandin (PG) E2, an activator of Gs, on MCh were constructed in the same way as ISO and other agents. In the fura-2 experiments, because the experiments must be carrried out under the condition that the loaded
fluorescence is steady, the experimental protocol described earlier was modified as follows: (1) the periods for application of MCh
and MCh with ISO were shortened to 7 min, (2) the periods for
washing out were shortened to 5 min, and (3) the control response to MCh after exposure to Lyso-PC was not examined.
Time-matched control tissues were treated similarly to the test
tissues but exposed continuously to the normal bathing solution
(sham incubation) instead of Lyso-PC, CTX, PTX, and BIS. The
subsequent relaxation by ISO after exposure to these agents was
compared with time-matched control tissues.
Materials
Lyso-PC (palmitoyl), MCh, ISO, CTX, PTX, BIS, forskolin, theophylline, db-cAMP, PGE2, and indomethacin were obtained from Sigma Chemical Co. (St. Louis, MO). Y-27632 was kindly provided by Welfide Corp. (Osaka, Japan).
Analysis of Results
All data are expressed as means ± standard deviation. The responses to an agent under each condition are described as percentages of the control response. Values of concentration of relaxant agents that produce 50% inhibition (EC50) of contraction induced by 1 µM MCh were determined using linear regression analysis applied to the linear portion of each concentration-response curve. Parameters were compared using the unpaired Student's t test, and P values of < 0.05 were considered statistically significant.
| |
Results |
|---|
|
|
|---|
Effects of Continuous Exposure to Lyso-PC on Subsequent
Response to
-Agonists
Application of 0.3 µM ISO caused a marked inhibition of 1 µM MCh-induced contraction; however, after exposure of the tissues to Lyso-PC (10 µM) for 15 min, inhibitory effects of ISO markedly attenuated (Figure 1A). Values of percent contraction for MCh with ISO inhibition after exposure to the normal bathing solution (control) and 10 µM Lyso-PC for 15 min were 9.5 ± 5.6% (n = 12) and 34.6 ± 9.4% (n = 12), respectively (P < 0.001). Pre-exposure to Lyso-PC caused a reduction in subsequent relaxation by ISO against MCh-induced contraction in a time-dependent manner (Figure 1B). When the tissues were exposed to an equimolar Lyso-PC for 60 min, values of percent contraction for MCh with ISO significantly increased to 67.9 ± 6.9 % (n = 12; P < 0.001), whereas those values after incubation with the normal bathing solution for an equivalent time were 10.6 ± 5.6% (n = 12). Moreover, when the period of exposure to Lyso-PC was prolonged to 120 min, subsequent response to ISO almost disappeared (Figures 1A and 1B) and values of percent contraction for MCh with ISO increased to 97.2 ± 2.9% (n = 12). Concentration-inhibition curves for ISO (0.0003 to 10 µM) on MCh were not affected after exposure to the normal bathing solution for 120 min, whereas these curves were markedly shifted to the right after exposure to 10 µM Lyso-PC for an equivalent time (Figure 1C). EC50 values for the curves for ISO after exposure to the normal bathing solution and 10 µM Lyso-PC for 120 min were 0.032 ± 0.009 (n = 8) and 6.1 ± 2.3 µM (n = 8), respectively (P < 0.0001). When MCh was cumulatively applied, 30 µM MCh produced the maximal contraction. Concentration-response curves for MCh (0.003 to 30 µM) were not affected after exposure to 10 µM Lyso-PC for 120 min (Figure 1D). EC50 values for the curves for MCh after exposure to the normal bathing solution and Lyso-PC for an equivalent time were 0.18 ± 0.08 (n = 6) and 0.21 ± 0.11 µM (n = 6), respectively (not significant).
|
Inhibitory Effects of Gs on the Reduced Responsiveness to
-Agonists by Lyso-PC
Preincubation with CTX caused a marked inhibition of reduction in subsequent relaxation by ISO after continuous exposure to Lyso-PC (Figure 2A). Values of percent contraction for MCh with ISO after exposure to 10 µM Lyso-PC for 120 min subsequent to incubation with the normal bathing solution and 2 µg/ml CTX for 6 h were 97.9 ± 1.5 (n = 8) and 14.9 ± 7.1% (n = 8), respectively (P < 0.001). In contrast, preincubation with PTX did not inhibit reduction in the relaxant effects of ISO induced by Lyso-PC (Figure 2A). Values of percent contraction for MCh with ISO after exposure to 10 µM Lyso-PC for 120 min subsequent to incubation with the normal bathing solution and 1 µg/ml PTX for 6 h were 96.9 ± 2.2 (n = 8) and 96.4 ± 2.8% (n = 8), respectively (not significant). Moreover, incubation with BIS also did not inhibit reduced responsiveness to ISO induced by Lyso-PC (Figure 2A). Values of percent contraction for MCh with ISO after exposure to 10 µM Lyso-PC in the absence and the presence of 5 µM BIS for 120 min were 97.1 ± 1.9 (n = 8) and 95.9 ± 3.8% (n = 8), respectively (not significant). PGE2 (0.1 to 300 nM) was cumulatively applied to the tissues precontracted by 1 µM MCh before and after exposure to 10 µM Lyso-PC for 120 min. PGE2 caused an inhibition of MCh-induced contraction in a concentration-dependent manner, however concentration-inhibition curves for PGE2 on MCh were not affected after exposure to Lyso-PC (Figure 2B). EC50 values for the curves for PGE2 after exposure to the normal bathing solution and Lyso-PC were 121.9 ± 38.6 (n = 8) and 172.3 ± 44.7 nM (n = 8), respectively (not significant).
|
Effects of Pre-exposure to Lyso-PC on Subsequent
Response to Agents that Bypass
-Adrenergic Receptors
We examined subsequent relaxation induced by agents that
bypass
-adrenergic receptors after exposure to Lyso-PC,
similar to Figures 1C and 2B. Forskolin (0.001 to 10 µM) was
cumulatively applied to the tissues precontracted by 1 µM
MCh before and after exposure to 10 µM Lyso-PC for 120 min. Concentration-inhibition curves for forskolin on MCh
were not affected after exposure to Lyso-PC (Figure 3A).
EC50 values for the curves for forskolin after exposure to
the normal bathing solution and Lyso-PC were 0.19 ± 0.09 (n = 8) and 0.22 ± 0.12 µM (n = 8), respectively (not significant). Theophylline (0.1 to 300 µM) was cumulatively
applied to the tissues precontracted by 1 µM MCh before
and after exposure to 10 µM Lyso-PC for an equivalent
time. Concentration-inhibition curves for theophylline on
MCh were also not affected after exposure to Lyso-PC
(Figure 3B). EC50 values for the curves for theophylline after exposure to the normal bathing solution and Lyso-PC
were 136.8 ± 41.2 (n = 8) and 184.9 ± 55.3 µM (n = 8), respectively (not significant). Further, db-cAMP (0.1 to
1,000 µM) was cumulatively applied to the tissues precontracted by 1 µM MCh before and after exposure to
equimolar Lyso-PC for an equivalent time. Concentration- inhibition curves for db-cAMP on MCh were not affected
after exposure to Lyso-PC (Figure 3C). EC50 values for the
curves for db-cAMP after exposure to the normal bathing
solution and Lyso-PC were 196.3 ± 25.4 (n = 8) and 210.6 ± 30.8 µM (n = 8), respectively (not significant).
|
Involvement of Ca2+ Sensitization in the Reduced
Responsiveness to
-Agonists Induced by Lyso-PC
To determine the effects of [Ca2+]i on subsequent reduction in relaxation by ISO after exposure to Lyso-PC, we continuously measured relationships between isometric tension and F340/F380 ratio. In the presence of ISO (0.3 µM), MCh (1 µM) was applied to the fura-2-loaded tissues for 7 min before and after exposure to 10 µM Lyso-PC for 15 min. Application of Lyso-PC did not affect basal tone or F340/F380 ratio (Figure 4A, lower trace). However, the relaxant effects of ISO on MCh-induced contraction were significantly reduced after exposure to Lyso-PC for 15 min, similar to the results in Figure 1 (Figure 4A, upper trace). Values of percent contraction for MCh with ISO after exposure to the normal bathing solution (n = 4) and Lyso-PC were 10.8 ± 4.1 and 37.9 ± 9.1% (n = 4), respectively (P < 0.001; Figure 4B). On the other hand, values of F340/F380 ratio did not increase after exposure to Lyso-PC (Figure 4A, lower trace). Values of percent F340/ F380 ratio for MCh with ISO after exposure to the normal bathing solution and Lyso-PC were 34.2 ± 8.2 (n = 4) and 35.1 ± 9.9% (n = 4), respectively (not significant; Figure 4C).
|
Involvement of Rho-Kinase in the Reduced Responsiveness
to
-Agonists Induced by Lyso-PC
To determine the mechanisms of reduced responsiveness
to
-agonists without any change in [Ca2+]i after exposure
to Lyso-PC, the relaxant action of
-agonists on MCh-
induced contraction was examined before and after exposure to Lyso-PC in the presence of Y-27632. The quantity
of 1 µM MCh was initially applied for 10 min (data not
shown), and after washing out for 15 min, 10 µM Y-27632
was applied. Then the same experiments as shown in Figure 1A were done in the presence of 10 µM Y-27632 throughout the experiments. The contraction induced by 1 µM MCh was attenuated in the presence of 10 µM Y-27632 and the
value of percent contraction for MCh was decreased to
63.2 ± 7.8% (n = 16; not shown). Although 0.001 µM Y-27632
did not change subsequent relaxation by ISO after exposure to 10 µM Lyso-PC for 120 min, Y-27632 caused an inhibition of reduced responsiveness to ISO induced by
Lyso-PC in a concentration-dependent manner (Figure 5A). Values of percent contraction for MCh with ISO after exposure to 10 µM Lyso-PC for 120 min in the presence of 0.001, 0.1, and 10 µM Y-27632 were 96.2 ± 3.1 (n = 8; not significant), 70.2 ± 5.6 (n = 8; P < 0.001), and 38.4 ± 6.9% (n = 8; P < 0.001), respectively (Figure 5B). The values of percent contraction for MCh with ISO after exposure to 10 µM Lyso-PC for 15 min in the presence of these
equivalent concentrations of Y-27632 were 32.9 ± 5.9 (n = 8; not significant), 18.7 ± 4.8 (n = 8; P < 0.001), and 4.9 ± 3.1% (n = 8; P < 0.001), respectively (Figure 5B). Moreover, the values of percent contraction for MCh with ISO
after exposure to 10 µM Lyso-PC for 60 min in the presence of the equivalent concentrations of Y-27632 were
63.1 ± 8.1 (n = 8; not significant), 42.8 ± 8.4 (n = 8; P < 0.001), and 22.8 ± 5.4% (n = 8; P < 0.001), respectively
(Figure 5B).
|
| |
Discussion |
|---|
|
|
|---|
In this study we examined the effects of continuous exposure to Lyso-PC on subsequent response to
-agonists in
airway smooth muscle. Extracellular exposure to Lyso-PC
caused a reduction in subsequent relaxation by
-agonists
in guinea-pig tracheal smooth muscle in a time-dependent
manner (Figure 1). However, the reduced responsiveness
to
-agonists by Lyso-PC occurred even though indomethacin was present throughout the experiments, different from
that induced by AA. Although AA plays an important
role in the subsequent reduction in response to
-agonists,
our results indicate that desensitization of
-adrenergic receptors induced by PLA2 may be mediated by Lyso-PC, independent of eicosanoid synthesis by AA. A reduction
in subsequent relaxation by ISO does not occur after exposure to 30 nM PGE2 in human tracheal smooth muscle
(15). Further, pre-exposure to 30 nM leukotriene D4 for
120 min did not cause a reduction in subsequent response
to ISO in guinea-pig tracheal smooth muscle (our unpublished observation). Chronic exposure to eicosanoids does
not always cause a reduction in subsequent responsiveness to
-agonists in airway smooth muscle.
In vessels, Lyso-PC is well known to inhibit endothelium-dependent relaxation by acethylcholine (16), and to
increase [Ca2+]i mediated by influx through a verapamil-sensitive channel (17). The effects of Lyso-PC are considered to be mediated by PKC (18) and Gi (19). However, in
guinea-pig tracheal smooth muscle, pre-exposure to 10 µM
Lyso-PC attenuated subsequent relaxation induced by
ISO via the independent pathways of PKC and Gi in the absence of epithelium (Figure 2), and moreover, did not affect subsequent contraction induced by MCh (Figure 1D).
These effects induced by continuous exposure to Lyso-PC
were mimicked when epithelium was present (our unpublished observation). These results indicate that the reduced
responsiveness to
-agonists by Lyso-PC is mediated by
nonepithelial processes in airway smooth muscle, and that
Lyso-PC does not affect muscarinic contraction in both
the presence and the absence of epithelium. In vascular
smooth muscle, a muscarinic receptor agonist leads to relaxation induced by endothelium-derived relaxation factors in the presence of endothelium, whereas this agent
leads to contraction in the absence of endothelium. In contrast, in airway smooth muscle, a muscarinic receptor agonist causes contraction under the condition of both the
presence and the absence of epithelium. Mechanical response to muscarinic receptor agonists via epithelium in
airways is not consistent with the response via endothelium in vessels. These differences in the mechanisms of exposure to Lyso-PC between airways and vessels may be
due to the differences between responses mediated by epithelium and endothelium.
Relaxant effects of agents that increase concentrations
of intracellular cAMP bypassing
-adrenergic receptors were
not affected after exposure to Lyso-PC in guinea-pig tracheal smooth muscle (Figure 3). The inhibitory effects of
PGE2, which activates Gs via PG receptors, were also not
affected after exposure to Lyso-PC (Figure 2B). Although
it is not currently known whether PLA2- and AA-induced
desensitization to
-agonists are mediated by homologous or heterologous desensitization, our results indicate that a
reduction in subsequent relaxation by
-agonists after exposure to Lyso-PC is mediated by homologous desensitization, and that after continuous exposure to Lyso-PC,
adenylyl cyclase/cAMP processes are still intact. Further,
as shown in Figure 2A, because irreversible activation of
Gs by CTX reversed the reduced mechanical response to
-agonists after continuous exposure to Lyso-PC, similar
to continuous exposure to
-agonists (12, 15), pre-exposure to Lyso-PC may cause damage to
-adrenergic receptor/G protein processes, and not to cAMP/cAMP-dependent PKA processes. Recently it has been revealed that Gs
protein dysfunction is involved in allergen-induced desensitization of
-adrenergic receptors in isolated passively
sensitized human bronchi (20). In transgenic mice in which
the
-subunit of Gs is overexpressed in myocardium, desensitization to
-agonists does not occur after chronic exposure to these agents (21). These results indicate that activation of Gs may lead to the prevention of
-adrenergic
desensitization. Moreover, in human platelets, extracellular application of Lyso-PC results in an augmentation of
membrane guanidine triphosphatase (GTPase) activity and
preincubation with CTX reduces the Lyso-PC-stimulated
increase in membrane GTPase by adenosine diphosphate
ribosylation of the
-subunit of Gs (22). The membrane
GTPase may be one of the affected proteins in the inhibitory effects of CTX on the reduced responsiveness to
-agonists induced by pre-exposure to Lyso-PC.
Previous reports have demonstrated that the number of
-adrenergic receptors markedly reduces after exposure
to PLA2 and AA in lung parenchyma (8, 23). Exposure to
Lyso-PC may lead to a reduction in the number of
-adrenergic receptors in airway smooth muscle, although the assay of the receptors was not examined in this study. However, a reduction in the mechanical response to
-agonists
after exposure to the agonists is not always associated with
the number of
-adrenergic receptors in airway smooth
muscle (24) because of the uncoupling of the receptors
with G proteins (25), and of the existence of spare receptors for
-adrenaline (26).
In vascular smooth muscle, Lyso-PC enhances contraction mediated by an increase in Ca2+ influx (27) or by Ca2+
sensitization (28), however little is currently known about the involvement of [Ca2+]i in a reduction in subsequent response to
-agonists in airway smooth muscle. In this
study, to determine which is involved in the
-adrenergic
desensitization by Lyso-PC, Ca2+ mobilization or Ca2+
sensitization, we simultaneously measured tension and
[Ca2+]i for MCh with ISO before and after exposure to
Lyso-PC. As shown in Figure 4, Lyso-PC has no direct effects on tension and [Ca2+]i in airway smooth muscle, different from vascular smooth muscle. However, after continuous exposure to Lyso-PC the inhibitory effects of ISO
markedly attenuated without an increase in F340/F380 ratio. Our results indicate that in airway smooth muscle the
reduced responsiveness to
-agonists by Lyso-PC is involved in an augmentation in Ca2+ sensitivity, not affecting Ca2+ mobilization, although the mechanisms of
-adrenergic desensitization induced by PLA2 and AA remain
unclear. Fura-2 fluorescence may be interfered with by
several endogenous fluorescent substances that are insensitive to Ca2+, leading to an error when the results are
quantitatively compared, as shown in Figure 4. However,
in preliminary experiments, the relationship between tension and F340/F380 ratio by 1 µM MCh was not affected
during the observation period (data not shown). Moreover, F340 and F380 always moved in opposite directions
throughout the experiments. Therefore, comparison of relative Ca2+ level may not be significantly affected by these
substances in this study.
Recent reports have demonstrated that rho enhances
sensitivity to Ca2+ mediated by myosin light chain processes in airway smooth muscle (29, 30), and that AA is
considered to contribute an ancillary pathway of rho-mediated Ca2+ sensitization in the permeabilized vascular smooth
muscle (31). We examined the involvement of rho in an augmentation in Ca2+ sensitivity induced by continuous exposure to Lyso-PC. Rho-kinase, which is a target protein of
rho (32), causes an augmentation in sensitivity to Ca2+ via
a reduction in myosin light chain phosphatase activity. The inhibition constant (Ki) value of Y-27632 for inhibiting
rho-kinase is generally considered to be 0.14 µM in vitro
(33). However, concentrations higher than 30 µM of Y-27632
cause an inhibition in PKA and PKC because Ki values of
Y-27632 for inhibiting these kinases are 25 and 26 µM, respectively (33). As shown in Figure 5, a reduction in subsequent relaxation by ISO after continuous exposure to Lyso-PC
was suppressed by 0.001 to 10 µM Y-27632, which is close
to the Ki value for inhibiting rho-kinase, in a concentration-dependent manner. The quantity of 10 µM Y-27632 caused an approximate 40% inhibition in the contraction
induced by 1 µM MCh in guinea-pig tracheal smooth muscle (our unpublished observation). Contraction induced by
1 µM MCh with 10 µM Y-27632 inhibition is roughly equivalent to contraction induced by 0.2 µM MCh. When the
concentration of MCh was lowered to 0.2 µM, the inhibitory effects of 0.3 µM ISO on 0.2 µM MCh were reduced
after exposure to Lyso-PC, similar to the results shown in
Figure 1 (our unpublished observation). These results indicate that prevention of the Lyso-PC-induced desensitization by Y-27632 may not be due to an inhibition in response to MCh by Y-27632. Therefore, pre-exposure to
Lyso-PC may lead to
-adrenergic desensitization precipitated by Ca2+ sensitization via rho/rho-kinase processes,
and a reduction in sensitivity to Ca2+ by inhibition of rho-kinase may prevent the
-adrenergic desensitization by
Lyso-PC. It is generally considered that Ca2+ sensitization
is involved in contraction by various agonists, including
MCh (29, 30). In this study, Lyso-PC induced Ca2+ sensitization by rho-kinase; however, MCh-induced contraction was not augmented after exposure to Lyso-PC. Although
our results are inconsistent with some previous reports,
other previous reports have demonstrated that cAMP-PKA
processes inhibit rho activity (34, 35). Rho activation induced by Lyso-PC may be more potent in a reduction in
relaxation by ISO than an augmentation in contraction by
MCh in guinea-pig tracheal smooth muscle. As shown in
Figure 3, cAMP-PKA processes are not involved in the
Lyso-PC-mediated
-adrenergic desensitization. There is
no evidence for the regulation of rho-dependent pathways
through Gs yet; however, our results suggest that a reduction in Gs activity leads to an augmentation in rho activity.
Rho GTPase may also be one of the affected proteins in
the
-adrenergic desensitization induced by Lyso-PC. Although interaction between "large" and "small" G proteins remains unclear, pre-exposure to Lyso-PC may act
on both the membrane GTPase and rho GTPase.
In conclusion, continuous exposure of airway smooth
muscle to Lyso-PC causes homologous desensitization of
-adrenergic receptors mediated by rho-induced Ca2+ sensitization. Preactivation of Gs prevents the reduced responsiveness to
-agonists induced by Lyso-PC. Our results may provide the evidence that sensitivity to
-agonists
is attenuated by PLA2/Lyso-PC processes in patients with
chronic asthma.
| |
Footnotes |
|---|
Address correspondence to: Hiroaki Kume, M.D., Ph.D., Second Dept. of Internal Medicine, School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan. E-mail: hkume{at}tsuru.med.nagoya-u.ac.jp
(Received in original form September 7, 2000 and in revised form February 22, 2001).
Abbreviations: arachidonic acid, AA; bisindolylmaleimide, BIS; intracellular Ca2+ concentration, [Ca2+]i; cyclic adenosine monophosphate, cAMP; cholera toxin, CTX; the stable analog of cAMP, db-cAMP; concentration of relaxant agents that produce 50% inhibition, EC50; acetoxymethyl ester of fura-2, fura 2/AM; PTX-sensitive G protein, Gi; the stimulatory G protein of adenylyl cyclase, Gs; guanidine triphosphatase, GTPase; isoproterenol, ISO; inhibition constant, Ki; lysophosphatidylcholine, Lyso-PC; methacholine, MCh; prostaglandin, PG; protein kinase, PK; phospholipase, PL; pertussis toxin, PTX.Acknowledgments: The authors thank Dr. Noriaki Kume (Department of Geriatric Medicine, School of Medicine, Kyoto University) for helpful comments.
| |
References |
|---|
|
|
|---|
1. Mehta, D., S. Gupta, S. N. Gaur, S. V. Gangel, and K. P. Agrawal. 1990. Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am. J. Respir. Dis. 142: 157-162 .
2. Nath, P., A. P. Joshi, and K. P. Agrawal. 1983. Biochemical correlates of airway hyperreactivity in guinea pigs: role of lysophosphatidylcholine. J. Allergy Clin. Immunol. 72: 351-358 [Medline].
3.
Chilton, F. H.,
F. J. Averill,
W. C. Hubbard,
A. N. Fonteh,
M. Triggiani, and
M. C. Liu.
1996.
Antigen-induced generation of lyso-phospholipids in human airways.
J. Exp. Med.
183:
2235-2245
4. Bowton, D. L., M. C. Seeds, M. B. Fasano, B. Goldsmith, and D. A. Bass. 1997. Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am. J. Respir. Crit. Care Med. 155: 421-425 [Abstract].
5. Kume, N., M. I. Cybulsky, and M. A. Gimbrone Jr.. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90: 1138-1144 .
6.
Willis-Karp, M.,
Y. Uchida,
J. Y. Lee,
J. Jinot,
A. Hirata, and
F. Hirata.
1993.
Organ culture with proinflammatory cytokines reproduces impairment of the
-adrenoceptor-mediated relaxation in tracheas of a guinea
pig antigen model.
Am. J. Respir. Cell Mol. Biol.
8:
153-159
.
7.
Nogami, M.,
D. J. Romberger,
S. I. Rennard, and
M. L. Toews.
1994.
TGF-
1 modulates
-adrenergic receptor number and function in cultured human tracheal smooth muscle cells.
Am. J. Physiol.
266:
L187-L191
8. Taki, F., K. Takagi, T. Satake, S. Sugiyama, and T. Ozawa. 1986. The role of phospholipase in reduced beta-adrenergic responsiveness in experimental asthma. Am. Rev. Respir. Dis. 133: 362-366 [Medline].
9. Omini, C., M. P. Abbracchio, E. Coen, L. Daffonchio, M. Fano, and F. Cattabeni. 1984. Involvement of arachidonic acid and metabolites in b-adrenoceptor desensitization: functional and biochemical studies. Eur. J. Pharmacol. 106: 601-606 [Medline].
10.
Daffonchio, L.,
M. P. Abbracchio,
A. Hernandez,
E. Giani,
F. Cattabeni, and
C. Omini.
1985.
Arachidonic acid metabolites induce
-adrenoceptor
desensitization in rat lung in vitro.
Prostaglandins
30:
799-809
[Medline].
11.
Kume, H.,
K. Mikawa,
K. Takagi, and
M. I. Kotlikoff.
1995.
Role of G proteins and KCa channels in the muscarinic and
-adrenergic regulation of
airway smooth muscle.
Am. J. Physiol.
268:
L221-L229
12.
Kume, H., and
K. Takagi.
1997.
Inhibitory effects of Gs on desensitization of
-adrenergic receptors in tracheal smooth muscle.
Am. J. Physiol.
273:
L556-L564
13. Satake, K., K. Takagi, I. Kodama, H. Honjo, J. Toyama, and S. Shibata. 1998. Relaxant effects of NKH477, a new water-soluble forskolin derivative, on guinea-pig tracheal smooth muscle: the role of Ca2+-activated K+ channels. Br. J. Pharmacol. 123: 753-761 [Medline].
14.
Konishi, M.,
A. Olson,
S. Hollingworth, and
S. M. Baylor.
1988.
Myoplasmic
binding of fura-2 investigated by steady-state fluorescence and absorbance
measurements.
Biophys. J.
54:
1089-1104
15.
Kume, H., and
K. Takagi.
1999.
Inhibition of
-adrenergic desensitization
by KCa channels in human trachealis.
Am. J. Respir. Crit. Care Med.
159:
452-460
16. Kugiyama, K., S. A. Kerns, J. D. Morrisett, R. Roberts, and P. D. Henry. 1990. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344: 160-162 [Medline].
17.
Stoll, L. L., and
A. A. Spector.
1993.
Lysophosphatidylcholine causes cGMP-dependent varapamil-sensitive Ca2+ influx in vascular smooth muscle.
Am.
J. Physiol.
264:
C885-C893
18.
Kugitama, K.,
M. Ogushi,
S. Sugiyama,
T. Murohara,
K. Fukunaga,
E. Miyamoto, and
H. Yasue.
1992.
Lysophosphatidylcholine inhibits surface
receptor-mediated intracellular signals in endothelial cells by a pathway
involving protein kinase C activation.
Circ. Res.
71:
1422-1428
19.
Flavahan, N. A..
1993.
Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells.
Am. J. Physiol.
264:
H722-H727
20.
Song, P.,
M. Milanese,
E. Crime,
S. Bruzzone,
E. Zocchi,
K. Rehder, and
V. Brusasco.
2000.
Gs protein dysfunction in allergen-challenged human isolated passively sensitized bronchi.
Am. J. Physiol.
279:
L209-L215
21.
Vanter, D. E.,
K. Asai,
M. Iwase,
Y. Ishikawa,
T. E. Wanger,
R. P. Shannon,
C. J. Homcy, and
S. F. Vanter.
1998.
Overexpression of myocardial Gs
prevents full expression of cathecholamine desensitization despite increased
-adrenergic receptor kinase.
J. Clin. Invest.
101:
1916-1922
[Medline].
22.
Yuan, Y.,
S. M. Schoenwaelder,
H. H. Salem, and
S. P. Jackson.
1996.
The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase.
J. Biol. Chem.
271:
27090-27098
23.
Raaijmarkers, J. A. M.,
H. J. Harmsen,
E. D. Boer,
C. Beneker, and
R. J. Van Rozen.
1986.
Phospholipase A2 products induce pulmonary
-adrenoceptor deviations.
Eur. J. Pharmacol.
127:
163-164
[Medline].
24.
Nishikawa, N.,
J. C. W. Mak,
H. Shirasaki,
S. E. Harding, and
P. J. Barnes.
1994.
Long-term exposure to norepinephrine results in down-regulation and reduced expression of pulmonary
-adrenergic receptors.
Am. J. Respir. Cell
Mol. Biol.
10:
91-99
[Abstract].
25.
Hausdroff, W. P.,
M. C. Caron, and
R. J. Lefkowitz.
1990.
Turning off the signal: desensitization of
-adrenergic receptor function.
FASEB J.
4:
2282-2289
.
26. Barnes, P. J.. 1995. Beta-adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med. 152: 838-860 [Medline].
27. Locher, R., B. Weisser, T. Mengden, C. Brunner, and W. Vetter. 1992. Lysolecithin action on vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 183: 156-162 [Medline].
28.
Jensen, P. E.,
J. Ohanian,
B. Stausbol-Gron,
N. H. Buus, and
C. Aalkjaer.
1996.
Increase by lysophosphatidylcholines of smooth muscle Ca2+ sensitivity in
-toxin-permeabilized small mesenteric artery from the rat.
Br. J. Pharmacol.
117:
1238-1244
[Medline].
29.
Croxton, T. L.,
B. Lande, and
C. A. Hirshman.
1998.
Role of G proteins in
agonist-induced Ca2+ sensitization of tracheal smooth muscle.
Am. J. Physiol.
275:
L748-L755
30.
Yoshii, A.,
K. Iizuka,
K. Dobashi,
T. Horie,
T. Harada,
T. Nakazawa, and
M. Mori.
1999.
Relaxation of contracted rabbit tracheal and human bronchial smooth muscle cells.
Am. J. Respir. Cell Mol. Biol.
20:
1190-1200
31.
Fu, X.,
M. C. Gong,
T. Jia,
A. V. Somlyo, and
A. P. Somlyo.
1998.
The effects of the Rho-kinase inhibitor Y-27632 on arachidonic acid-, GTP
s-,
and phorbol ester-induced Ca2+-sensitization of smooth muscle.
FEBS
Lett.
440:
183-187
[Medline].
32. Kimura, K., M. Ito, M. Amano, K. Chihara, Y. Fukata, M. Nakafuku, B. Yamamori, J. Feng, T. Nakano, K. Okawa, A. Iwamatsu, and K. Kaibuchi. 1996. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248 [Abstract].
33. Uehata, M., T. Ishizaki, H. Sato, T. Ono, T. Kawahara, T. Morishita, H. Tamakawa, K. Yamagami, J. Inui, M. Maekawa, and S. Narumiya. 1997. Calcium sensitization of smooth muscle mediated by a rho-associated protein kinase in hypertension. Nature 389: 990-994 [Medline].
34. Lang, P., F. Gesbert, M. Delespine-Carmagnat, R. Stancou, M. Pouchelet, and J. Bertoglio. 1996. Protein kinase A phosphorylation of rhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J. 15: 510-519 [Medline].
35.
Landanna, C.,
J. J. Campbell, and
E. C. Butcher.
1997.
Elevation of intracellular cAMP inhibits rhoA activation and integrin-dependent leukocyte adhesion induced by chemoattractants.
J. Biol. Chem.
272:
24141-24144
This article has been cited by other articles:
![]() |
H. Kume, N. Takeda, T. Oguma, S. Ito, M. Kondo, Y. Ito, and K. Shimokata Sphingosine 1-Phosphate Causes Airway Hyper-Reactivity by Rho-Mediated Myosin Phosphatase Inactivation J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 766 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Takeda, M. Kondo, S. Ito, Y. Ito, K. Shimokata, and H. Kume Role of RhoA Inactivation in Reduced Cell Proliferation of Human Airway Smooth Muscle by Simvastatin Am. J. Respir. Cell Mol. Biol., December 1, 2006; 35(6): 722 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kume, T. Ishikawa, T. Oguma, S. Ito, K. Shimokata, and M. I. Kotlikoff Involvement of Ca2+ Mobilization in Tachyphylaxis to {beta}-Adrenergic Receptors in Trachealis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 359 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ito, H. Kume, K. Yamaki, H. Katoh, H. Honjo, I. Kodama, and H. Hayashi Regulation of Capacitative and Noncapacitative Receptor-Operated Ca2+ Entry by Rho-Kinase in Tracheal Smooth Muscle Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 491 - 498. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |